Michael McInerney

Michael is an Executive Director leading Digital Health within the Business Development Innovative Technologies function at Bristol Myers Squibb. Michael is responsible for evaluation and execution of Business Development investments and transactions in support of Digital Innovation priorities at BMS. 

During his 28 years at Bristol Myers Squibb, Michael has worked across Europe, Asia Pacific and the US in a variety of roles leading and developing high performing, diverse teams, while growing his responsibility and knowledge of the Biopharmaceutical Industry.

Prior to his current role, Michael had responsibility for Alliance Management with a specific focus on late-stage partnerships including: clinical collaborations, translational medicine and diagnostics partnerships, digital partnerships as well as commercial alliances.

Michael has also held roles at BMS responsible for oversight of IT, Infrastructure, and adjacent services in support of Business Development priorities (M&A, divestitures, strategic alliances, collaborations and licensing) at Bristol Myers Squibb. This involved the full spectrum of the deal lifecycle from pre-deal diligence, operational and synergy reviews, ‘Day-1’ planning and post-deal implementation support.

In addition to his IT/Corporate Services experience in supporting Business Development, Michael has supported Manufacturing Operations Globally, Product & Process Development, Engineering & Quality functions.

Michael began his career in Ireland as Chemist with Bristol Myers Squibb in 1994, after completing his Bachelor of Science Degree in Industrial Chemistry and Business Administration postgraduate studies. Michael currently resides in Princeton, NJ.